[{"address1": "121 Richmond Street West", "address2": "Penthouse Suite, 1300", "city": "Toronto", "state": "ON", "zip": "M5H2K1", "country": "Canada", "phone": "416-346-7764", "website": "https://www.psyencebiomed.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company's lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for treatment of anxiety and depression, including associated ailments, such as post-traumatic stress disorder PTSD, stress, grief, and adjustment disorder in the context of palliative care. It has a partnership with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010 in psilocybin-assisted psychotherapy for the treatment of AjD due to incurable cancer. The company is based in Toronto, Canada. Psyence Biomedical Ltd. operates as a subsidiary of Psyence Group Inc.", "fullTimeEmployees": 12, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jody  Aufrichtig", "age": 50, "title": "Co-Founder, Executive Chairman & Strategic Business Development Officer", "yearBorn": 1974, "fiscalYear": 2025, "totalPay": 216667, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Neil  Maresky M.D.", "age": 60, "title": "CEO & Director", "yearBorn": 1964, "fiscalYear": 2025, "totalPay": 390000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Warwick Ron Corden-Lloyd", "age": 44, "title": "Chief Financial Officer", "yearBorn": 1980, "fiscalYear": 2025, "totalPay": 195000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Taryn  Vos", "title": "General Counsel", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 5.245, "open": 5.2, "dayLow": 5.0, "dayHigh": 5.37, "regularMarketPreviousClose": 5.245, "regularMarketOpen": 5.2, "regularMarketDayLow": 5.0, "regularMarketDayHigh": 5.37, "payoutRatio": 0.0, "beta": 0.146, "trailingPE": 0.124597706, "volume": 24612, "regularMarketVolume": 24612, "averageVolume": 98356, "averageVolume10days": 70340, "averageDailyVolume10Day": 70340, "bid": 3.68, "ask": 6.65, "bidSize": 2, "askSize": 2, "marketCap": 3034834, "fiftyTwoWeekLow": 2.936, "fiftyTwoWeekHigh": 702.0, "fiftyDayAverage": 4.55028, "twoHundredDayAverage": 22.15233, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -5755297, "profitMargins": 0.0, "floatShares": 71171, "sharesOutstanding": 583263, "sharesShort": 15310, "sharesShortPriorMonth": 34037, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.026199998, "heldPercentInsiders": 0.00483, "heldPercentInstitutions": 0.11128, "shortRatio": 0.09, "shortPercentOfFloat": 0.026600001, "impliedSharesOutstanding": 606879, "bookValue": 94.317, "priceToBook": 0.055167146, "lastFiscalYearEnd": 1743379200, "nextFiscalYearEnd": 1774915200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": 1011790, "trailingEps": 41.76, "lastSplitFactor": "125:1000", "lastSplitDate": 1746403200, "enterpriseToEbitda": 1.573, "52WeekChange": -0.97019017, "SandP52WeekChange": 0.12632763, "quoteType": "EQUITY", "currentPrice": 5.2032, "recommendationKey": "none", "totalCash": 6135166, "totalCashPerShare": 86.083, "ebitda": -3658754, "totalDebt": 0, "quickRatio": 10.553, "currentRatio": 11.037, "returnOnAssets": -0.54196, "freeCashflow": -3394860, "operatingCashflow": -3734238, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PBM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "firstTradeDateMilliseconds": 1639146600000, "corporateActions": [], "regularMarketTime": 1751387951, "exchange": "NCM", "messageBoardId": "finmb_698500412", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.7969499, "regularMarketPrice": 5.2032, "shortName": "Psyence Biomedical Ltd.", "longName": "Psyence Biomedical Ltd.", "epsTrailingTwelveMonths": 41.76, "fiftyDayAverageChange": 0.65291977, "fiftyDayAverageChangePercent": 0.14349002, "twoHundredDayAverageChange": -16.949131, "twoHundredDayAverageChangePercent": -0.7651173, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-01-26", "cryptoTradeable": false, "hasPrePostMarketData": true, "regularMarketChange": -0.041800022, "regularMarketDayRange": "5.0 - 5.37", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 98356, "fiftyTwoWeekLowChange": 2.2671998, "fiftyTwoWeekLowChangePercent": 0.77220696, "fiftyTwoWeekRange": "2.936 - 702.0", "fiftyTwoWeekHighChange": -696.7968, "fiftyTwoWeekHighChangePercent": -0.99258804, "fiftyTwoWeekChangePercent": -97.01902, "marketState": "REGULAR", "displayName": "Psyence Biomedical", "trailingPegRatio": null, "__fetch_time": "2025-07-01"}]